Aastik Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.37 M
- Revenue Growth 580.75%
- Profit Growth 112.20%
- Ebitda 4647.85%
- Net Worth 12.33%
- Total Assets 30.16%
About Aastik Pharma
Aastik Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 August 2009 and has a history of 15 years and six months. Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹2.37 M.
Muniswamy Basker and Basker Hamsaveni serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230TZ2009PTC015387
-
Company No.
015387
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Aug 2009
-
Date of AGM
25 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Aastik Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muniswamy Basker
|
Managing Director | 07-Aug-2009 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Basker Hamsaveni
|
Director | 07-Aug-2009 | Current |
Financial Performance of Aastik Pharma.
Aastik Pharma Private Limited, for the financial year ended 2012, experienced significant growth in revenue, with a 580.75% increase. The company also saw a substantial improvement in profitability, with a 112.2% increase in profit. The company's net worth Soared by an impressive increase of 12.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aastik Pharma?
In 2018, Aastik Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.37 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Oct 2009 | State Bank Of India | ₹2.37 M | Open |
How Many Employees Work at Aastik Pharma?
Unlock and access historical data on people associated with Aastik Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aastik Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aastik Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.